ZIOPHARM Oncology, Inc. announced that as part of the workforce reduction, Kevin G. Lafond, Sr. Vice President Finance, Chief Accounting Officer and Treasurer, is separating from the Company effective November 8, 2021; provided that the Company has the option of extending his employment through a later date. In connection with his separation, Mr. Lafond will receive a severance payment of approximately $0.2 million.